Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment.

European review for medical and pharmacological sciences - 1 Nov 2024

Teke Z, Bisgin A, Oruc Rencuzogullari C, Eren Erdogan K, Parsak C K, Kalkanli Tas S

Abstract excerpt

OBJECTIVE: Next-generation sequencing (NGS) has been offered as a large-scale and effective genomic analyzing tool. In this research, we seek to examine the possible benefits of an actionable mutation panel in association with clinical and pathological features in the treatment of esophageal cancer. PATIENTS AND METHODS: In our study, 85 cases whose diagnosis of carcinoma was confirmed histopathologically either...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Esophageal Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ERBB3 gene

Share to PIK3CA gene

Share to ROS1 gene

Share to High-Throughput Nucleotide Sequencing

Share to Mutation

Share to Prognosis

Source

Identifiers

PMID: 39560927
DOI: 10.26355/eurrev_202411_36910

Genes

PIK3CA
AKT1
ALK
BRAF
EGFR
ERBB2
ERBB3
ESR1
FGFR1
KIT
KRAS
MAP2K1
MET
NRAS
PDGFRA
PTEN
RICTOR
ROS1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic significance of actionable next-generation sequencing multigene panel in esophageal cancer treatment.PMID 39560927Read ↗

Actionable Alterations for Molecular Targeted Therapy in Esophageal Cancer: An AACR Project GENIE ReviewSemantic proximity Read ↗

Clinical impact of panel gene sequencing on therapy of advanced cancers of the digestive system: a retrospective, single center study.Semantic proximity Read ↗

Tumor profiling of gastric and esophageal carcinoma reveal different treatment options.Semantic proximity Read ↗

Targeted next generation sequencing identified clinically actionable mutations in patients with esophageal sarcomatoid carcinoma.Semantic proximity Read ↗

Comprehensive molecular profiling of Taiwanese breast cancers revealed potential therapeutic targets: prevalence of actionable mutations among 380 targeted sequencing analyses.Semantic proximity Read ↗

Clinical Actionability of Genes in Gastrointestinal TumorsSemantic proximity Read ↗

NGS-based targeted gene mutational profiles in Korean patients with pancreatic cancerSemantic proximity Read ↗

Whole genome sequencing in oesophageal adenocarcinoma unmasks potential precision therapies.Semantic proximity Read ↗

Clinical and diagnostic utility of genomic profiling for digestive cancers: real-world evidence from JapanSemantic proximity Read ↗

Characteristics and response to next-generation sequencing-guided therapy in locally advanced or metastatic esophageal cancer.Semantic proximity Read ↗

Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancerSemantic proximity Read ↗

Targeted Gene Next-Generation Sequencing Panel in Patients with Advanced Lung Adenocarcinoma: Paving the Way for Clinical ImplementationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.